See also this year's filing and all EDGAR filings for this company.
PDF Report 0001708331_2022_Virpax_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001708331, Virpax Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 39,572,436 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 2,087,691 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,186,385 |
| 9 | ResearchAndDevelopmentExpense | 4,839,115 |
| 10 | remainder_Expenses | 92,822 |
| 11 | remainder_Revenues | 62,259 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 39,572,436 |
| 1 | Liabilities | 2,087,691 |
| 2 | Expenses | 12,118,322 |
| 3 | Revenues | 62,259 |
| 4 | StockholdersEquity | 37,484,745 |
| 5 | NetIncome | -12,056,063 |
| 6 | ComprehensiveNetIncome | -12,056,063 |
| 7 | BaseVar | 26,920,354 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.34 |
| 9 | EconomicCapitalRatio | 3.92 |
Edgar->Model Mapping
Feature Distribution
